Jupiter Biomedical Research is a preclinical
#16 of 55 therapeutics startups
▲ 1 since the last ranking
Ranked 6:02 AM PT · Thu, Nov 19
Listed
Jupiter Biomedical Research is a preclinical, IND-enabling biotech advancing two patented oral small-molecule therapeutic candidates: JBR-102 for cancer (glioblastoma lead) and JBR-201 as a broad-spectrum antiviral. First human clinical studies planned for 2027.
If a fact is wrong, or you want the profile removed, tell us: we act on every request within 2 business days.